Volume 224 - Published ahead of Issue 10
Beyond Fibrosis Stratification: Integrating Behavioural, Metabolic and Policy-Level Interventions in Metabolic Dysfunction-Associated Steatotic Liver Disease
Authors: Yousef Hakimi, Prarthana Thiagarajan, Michael Braude
Correspondence: yousef.hakimi@monashhealth.org
Med J Aust 2026 || doi: 10.5694/mja2.70309
Published online: 29 September 2026
Published online: 29 September 2026
Abstract
To the Editor,
We read with interest the review by Vaz and colleagues [1] examining metabolic dysfunction-associated steatotic liver disease (MASLD) in Australia. They should be commended on synthesising epidemiological data and emphasising fibrosis as the principal determinant of liver-related morbidity and mortality. Their focus on fibrosis risk stratification, using the Fibrosis-4 Index followed by vibration-controlled transient elastography or enhanced liver fibrosis testing, reflects international consensus and is pragmatic and scalable given rising disease prevalence [2].
...
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
Karl Vaz, Daniel Clayton-Chubb, William W. Kemp, Stuart K. Roberts, Ammar Majeed
When ‘Liver Enzymes’ Are Not Hepatic: Late-Onset Pompe Disease
Shauna Madigan, Georgina England, Wayne Rankin
Fatty Liver Disease in Australia: A Narrative Review on the Epidemiology, Natural History, Prognostication and Management in People With Metabolic Dysfunction
Karl Vaz, Daniel Clayton-Chubb, William W. Kemp, Stuart K. Roberts, Ammar Majeed
The early implementation phase of the Omega‐3 Test‐and‐Treat Program for reducing the risk of preterm birth, South Australia, 2021–22: an implementation evaluation study
Karen P Best, Celine Northcott, Lucy A Simmonds, Philippa Middleton, Lisa N Yelland, Vanessa Moffa, Khoa Lam, Penelope Coates, Cornelia Späth, Carol WK Siu, Karen Glover, Rhiannon Smith, Robert Gibson, Maria Makrides
Cause‐specific mortality among Queensland people with cirrhosis, by cirrhosis aetiology and decompensation status, 2007–22: a retrospective cohort study
Vikas Bhasker, Jessica R Fong, Paul J Clark, Gunter F Hartel, Richard Skoien, James O’Beirne, Elizabeth E Powell, Patricia C Valery